24 completed, 15 active not recruiting, 13 terminated, 3 recruiting. 27 Not applicable, 12 Phase 2, 9 Phase 1, 2 Phase 3, 1 Early Phase 1.
Follow Prognostic Stage I Breast Cancer AJCC v8: new trials by email Literature Review of Prognostic Stage I Breast Cancer AJCC v8 trials Research Report on Prognostic Stage I Breast Cancer AJCC v8
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer Ipilimumab, Pembrolizumab, Vaccine Therapy - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 | Phase 1 | Recruiting | Emory University | 18 | 2025-12-02 | 2026-01-26 |
| Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer Minoxidil, Quality-of-Life Assessment, Questionnaire Administration - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 | Early Phase 1 | Recruiting | Ohio State University Comprehensive Cancer Center | 50 | 2023-03-01 | 2026-03-10 |
| Health Coaching-Based Navigation at the Conclusion of Treatment for the Support of Black Breast Cancer Survivors Patient Navigation, Quality-of-Life Assessment, Questionnaire Administration - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 | Not applicable | Completed | Ohio State University Comprehensive Cancer Center | 21 | 2022-11-14 | 2025-03-25 |
| Transcutaneous Electrical Nerve Stimulation in Chemotherapy Induced Peripheral Neuropathy in Patients With Stage I-III Early Stage Breast Cancer Transcutaneous Electrical Nerve Stimulation - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 | Not applicable | Terminated | Emory University | 17 | 2022-10-19 | 2026-05-18 |
| Precision Performance Status Assessment in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy Behavioral Assessment, Electronic Health Record Review - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 | Terminated | M.D. Anderson Cancer Center | 27 | 2022-08-15 | 2024-08-26 | |
| Diabetes Prevention Program (METFIT) in Reducing Insulin Resistance in Stage I-III Breast Cancer Survivors Dietary Intervention - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 | Not applicable | Withdrawn | City of Hope Medical Center | 2022-06-15 | 2022-06-09 | |
| Piloting Y-AMBIENT: A Quality of Life Intervention for Young African American Breast Cancer Survivors Educational Intervention, Quality-of-Life Assessment, Questionnaire Administration - Breast Cancer, Anatomic Stage I Breast Cancer AJCC v8 | Not applicable | Terminated | University of Alabama at Birmingham | 27 | 2022-06-01 | 2026-05-07 |
| A Quality of Life Intervention for Young African American Breast Cancer Survivors in Treatment Best Practice, Educational Intervention, Quality-of-Life Assessment - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 | Not applicable | Terminated | University of Alabama at Birmingham | 37 | 2022-06-01 | 2026-05-06 |
| Standard Verbal Counseling With or Without a Pictorial Educational Tool for the Reduction of Psychological Morbidity in Patients With Stage 0-IIIA Breast Cancer Receiving Radiation Therapy, COPE Study Counseling, Educational Intervention, Questionnaire - Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | Not applicable | Active not recruiting | OHSU Knight Cancer Institute | 62 | 2022-03-18 | 2026-09-15 |
| Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors Medical Device Usage and Evaluation, Quality-of-Life Assessment, Survey Administration - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 | Active not recruiting | University of Southern California | 173 | 2021-11-24 | 2026-10-05 | |
| An Episodic Future Thinking Intervention to Promote Weight Loss in Breast Cancer Survivors Behavioral Intervention, Quality-of-Life Assessment, Questionnaire Administration - Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | Not applicable | Completed | Ohio State University Comprehensive Cancer Center | 50 | 2021-11-01 | 2025-02-07 |
| Mobile Health to Improve Oral Chemotherapy Adherence Among Women With Breast Cancer Best Practice, Informational Intervention, Medical Device Usage and Evaluation - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 | Not applicable | Completed | Emory University | 33 | 2021-10-22 | 2025-06-17 |
| Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel Cimetidine, Dexamethasone, Diphenhydramine - Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | Phase 2 / Phase 3 | Completed | Ohio State University Comprehensive Cancer Center | 130 | 2021-10-07 | 2025-08-20 |
| Oxaloacetate for the Improvement of Cognitive Complaints in Stage 0-IIIA Breast Cancer Survivors Anhydrous Enol-oxaloacetate, Questionnaire Administration - Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | Phase 2 | Completed | Jonsson Comprehensive Cancer Center | 18 | 2021-09-29 | 2025-07-15 |
| Culturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stage 0-III Breast Cancer Survivors, Writing to Heal Study Behavioral, Psychological or Informational Intervention, Best Practice, Quality-of-Life Assessment - Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | Not applicable | Active not recruiting | M.D. Anderson Cancer Center | 256 | 2021-07-23 | 2026-08-21 |
| Web-Based Symptom Monitoring and Self-Management Portal (YES) for Adolescent and Young Adult Breast Cancer Survivors Best Practice, Internet-Based Intervention, Survey Administration - Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | Not applicable | Active not recruiting | Ohio State University Comprehensive Cancer Center | 400 | 2021-06-28 | 2026-02-19 |
| Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer Abemaciclib, Niraparib Tosylate Monohydrate - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 | Phase 1 | Completed | OHSU Knight Cancer Institute | 8 | 2021-06-07 | 2026-01-29 |
| Radiation Therapy Boost Before Surgery for the Treatment of Non-metastatic Breast Cancer Quality-of-Life Assessment, Questionnaire Administration, Radiation Boost - Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | Not applicable | Active not recruiting | Rutgers, The State University of New Jersey | 103 | 2021-05-18 | 2026-01-22 |
| Treatment Decision Making in African American Women Diagnosed With Triple Negative Breast Cancer Discussion, Interview, Survey Administration - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 | Completed | M.D. Anderson Cancer Center | 30 | 2021-05-03 | 2023-08-09 | |
| Cognitive-Behavioral Stress Management Device for the Treatment of Anxiety and Depressive Symptoms in Patients With Stage I-III Breast or Lung Cancer Cognitive Behavior Therapy, Interview, Quality-of-Life Assessment - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 | Not applicable | Terminated | Jonsson Comprehensive Cancer Center | 5 | 2021-04-08 | 2023-07-25 |
Showing 20 of 59. Sign in to see all of them.
Breast Carcinoma In Situ (16) · Breast Neoplasms (11) · Triple Negative Breast Neoplasms (10) · Carcinoma, Intraductal, Noninfiltrating (5) · Ovarian Neoplasms (3) · Overweight (3) · Carcinoma, Non-Small-Cell Lung (2) · Lung Neoplasms (2) · Obesity (2) · Uterine Cervical Neoplasms (2) · Anxiety Disorders (1) · Arthralgia (1) · Bone Neoplasms (1) · Brain Neoplasms (1) · Carcinoma, Medullary (1)
Neoplasms (36) · Neoplasms by Site (33) · Breast Diseases (28) · Skin Diseases (28) · Skin and Connective Tissue Diseases (28) · Carcinoma (20) · Neoplasms by Histologic Type (20) · Neoplasms, Glandular and Epithelial (20) · Carcinoma in Situ (19) · Breast Neoplasms (17) · Adenocarcinoma (6) · Neoplasms, Ductal, Lobular, and Medullary (6) · Genital Diseases (5) · Pathological Conditions, Signs and Symptoms (5) · Signs and Symptoms (5)
Practice Guidelines as Topic (10) · Standard of Care (9) · Early Intervention, Educational (5) · Taxes (5) · Educational Status (4) · Interviews as Topic (4) · Methods (4) · Paclitaxel (4) · Behavior Therapy (2) · CTLA-4 Antigen (2) · Diet Therapy (2) · Ipilimumab (2) · Letrozole (2) · Magnetic Resonance Spectroscopy (2) · abemaciclib (2)
M.D. Anderson Cancer Center (12) · Ohio State University Comprehensive Cancer Center (10) · Mayo Clinic (8) · Jonsson Comprehensive Cancer Center (4) · Emory University (3) · Alliance for Clinical Trials in Oncology (2) · OHSU Knight Cancer Institute (2) · Roswell Park Cancer Institute (2) · Thomas Jefferson University (2) · University of Alabama at Birmingham (2) · University of Southern California (2) · Wake Forest University Health Sciences (2) · City of Hope Medical Center (1) · ECOG-ACRIN Cancer Research Group (1) · Fred Hutchinson Cancer Center (1)
United States (56) · Chile (1) · Colombia (1) · Mexico (1)
Lorenzo Cohen (2) · Meghan Karuturi (2) · Patricia A Ganz (2) · Senthilkumar Damodaran (2) · Timiya Nolan, PhD (2) · William Carson, MD (2) · Abenaa M Brewster (1) · Alexandra Zimmer, M.D. (1) · Anita H. Chen, M.D. (1) · Brent A. Bauer, M.D. (1) · Brian C Focht, PhD (1) · Bridget A Oppong, MD (1) · Brittany L Dulmage, MD (1) · Bruce G Haffty (1) · Bryan P Schneider (1)
PMID 33142018, PMID 34782341, PMID 35727609, PMID 35788100, PMID 36336249, PMID 36609349, PMID 37621406, PMID 37828596, PMID 38828938, PMID 39325778, PMID 39865083, PMID 40966714, PMID 42804742
P30CA138292 (3), P30CA012197 (2), P30CA014089 (2), UG1CA189823 (2), K08CA245208 (1), P30CA015083 (1), P30CA016058 (1), P30CA016672 (1), P30CA023074 (1), P30CA033572 (1), P30CA072720 (1), P50CA116201 (1), R01CA105023 (1), R01CA222246 (1), R01CA237046 (1)